secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2024-04-03T23:59:59+00:00
Accession:  0001193125-24-085435
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics audit committee falls to 2 members; Nasdaq grants cure period until Mar 2025
--------------------------------------------------------------------------------

- Susan Graf resigned from board on March 26, 2024, reducing audit committee to 2 independent directors.
- Nasdaq requires audit committee of 3 independent directors; company notified Nasdaq on March 28.
- Nasdaq notice received April 2; company has until March 26, 2025 or next annual meeting to regain compliance.
- If next annual meeting is before September 23, 2024, cure deadline is September 23, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524085435/0001193125-24-085435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524085435/d817910d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-085435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer